Stockscreener 앱 받기
12.06
6.94%
-0.90
시간 외 거래:
12.15
0.09
+0.75%
전일 마감가:
$12.96
열려 있는:
$12.78
하루 거래량:
711.32K
Relative Volume:
0.69
시가총액:
$377.36M
수익:
-
순이익/손실:
$-69.47M
주가수익비율:
-2.1546
EPS:
-5.5973
순현금흐름:
$-73.92M
1주 성능:
-10.80%
1개월 성능:
-13.67%
6개월 성능:
-71.27%
1년 성능:
-47.27%
1일 변동 폭
$11.92
$12.98
1주일 범위
$11.92
$14.97
52주 변동 폭
$11.48
$50.40
Lenz Therapeutics Inc Stock (LENZ) Company Profile
명칭
Lenz Therapeutics Inc
전화
858-925-7000
주소
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Compare LENZ vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
12.06 | 405.52M | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-14 | 재개 | Piper Sandler | Overweight |
| 2025-03-18 | 개시 | TD Cowen | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-12 | 개시 | H.C. Wainwright | Buy |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2024-04-15 | 개시 | William Blair | Outperform |
| 2024-04-10 | 개시 | Citigroup | Buy |
| 2024-03-27 | 개시 | Piper Sandler | Overweight |
| 2023-02-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-02-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2023-01-25 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-01-06 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-04-14 | 개시 | BTIG Research | Buy |
| 2022-03-22 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | 개시 | Morgan Stanley | Overweight |
| 2021-07-20 | 개시 | SVB Leerink | Outperform |
모두보기
Lenz Therapeutics Inc 주식(LENZ)의 최신 뉴스
Presbyopia Pipeline 2026: 10+ Companies, 10+ Emerging Therapies, and 3 Key FDA NDA Milestones Driving the Future of Vision Care, analyses DelveInsight - StreetInsider
LENZ: Strong launch momentum for a new presbyopia eye drop, with robust efficacy and market uptake - TradingView
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
LENZ Therapeutics (NASDAQ:LENZ) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Should You Buy LENZ Therapeutics Inc (LENZ) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
LENZ Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Bearish Setup: What are LENZ Therapeutics Incs recent SEC filings showingMarket Activity Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
LENZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Versant Venture Management LLC Buys Shares of 2,656,888 LENZ Therapeutics, Inc. $LENZ - MarketBeat
LENZ Therapeutics to Present at Upcoming Investor Conferences - LENZ Therapeutics
Presbyopia eye-drop firm LENZ lines up two investor conferences - Stock Titan
Risk Check: Can LENZ Therapeutics Inc sustain its profitabilityGold Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
LENZ Therapeutics (NASDAQ:LENZ) Rating Lowered to Sell at Wall Street Zen - MarketBeat
What’s the beta of LENZ Therapeutics Inc. stockQuarterly Profit Review & Breakout Confirmation Trade Signals - mfd.ru
Breakout Move: What are LENZ Therapeutics Incs recent SEC filings showingWeekly Gains Summary & High Yield Equity Trading Tips - baoquankhu1.vn
Weekly Earnings: Can LENZ Therapeutics Inc reach all time highs this yearMarket Trend Review & Safe Entry Zone Tips - baoquankhu1.vn
LENZ Therapeutics, Inc. $LENZ Shares Acquired by Skandinaviska Enskilda Banken AB publ - MarketBeat
Ridgeback exits Lenz Therapeutics (LENZ) with 0% reported ownership stake - Stock Titan
Short Interest in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Decreases By 16.8% - MarketBeat
How LENZ Therapeutics Inc. stock compares to market leaders2025 EndofYear Setup & Fast Gain Stock Trading Tips - mfd.ru
LENZ Therapeutics (LENZ) Stock Analysis: Eyeing A 295% Upside In The Biotech Arena - DirectorsTalk Interviews
Analyst Upgrade: Can LENZ Therapeutics Inc disrupt its industryNew Guidance & Consistent Income Trade Recommendations - baoquankhu1.vn
Why is LENZ Therapeutics Inc. stock going upWeekly Stock Report & Reliable Price Action Trade Plans - mfd.ru
Fund Flows: What is the cash position of LENZ Therapeutics IncEarnings Recap Report & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Can LENZ Therapeutics Inc. benefit from deglobalizationJuly 2025 Momentum & Low Risk Growth Stock Ideas - mfd.ru
Is LENZ Therapeutics Inc. stock a value trapBreakout Watch & Advanced Technical Signal Analysis - mfd.ru
Is LENZ Therapeutics Inc. benefiting from interest rate changesWeekly Trading Summary & Low Risk High Win Rate Picks - mfd.ru
Guidance Update: Can LENZ Therapeutics Inc be the next market leaderEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn
No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod - MSN
Investment Recap: Why is LENZ Therapeutics Inc stock going upQuarterly Profit Review & Growth Focused Entry Point Reports - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), LENZ Therapeutics (LENZ) and Amgen (AMGN) - The Globe and Mail
Lenz Therapeutics price target lowered to $35 from $52 at BofA - TipRanks
LENZ Therapeutics stock price target lowered to $35 at BofA on slower ramp - Investing.com Canada
LENZ Therapeutics stock price target lowered to $35 at BofA on slower ramp By Investing.com - Investing.com South Africa
Why Is LENZ Therapeutics Stock Trading Lower Today?LENZ Therapeutics (NASDAQ:LENZ) - Benzinga
What is the cash position of LENZ Therapeutics Inc.July 2025 Closing Moves & Fast Exit Strategy with Risk Control - mfd.ru
Is LENZ Therapeutics Inc. stock a buy or sell2025 Biggest Moves & Precise Buy Zone Tips - mfd.ru
Tenpoint advantage? FDA clears presbyopia duo-drop - bioworld.com
Bull Run: Will LENZ Therapeutics Inc outperform its industry peersJuly 2025 Retail & High Win Rate Trade Tips - baoquankhu1.vn
LENZ Therapeutics and Sarah Jessica Parker Launch ‘Make it VIZZable’ Campaign - VisionMonday.com
In first celebrity partnership, Lenz Therapeutics taps Sarah Jessica Parker for vision campaign - Medical Marketing and Media
Insider Trends: Is Okeanis Eco Tankers Corp a defensive stockEarnings Growth Report & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Sovran Advisors LLC Has $4.98 Million Stock Holdings in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Aug PostEarnings: Why is LENZ Therapeutics Inc stock going up2025 Support & Resistance & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Nasdaq Moves: Why is LENZ Therapeutics Inc stock going upRate Hike & Daily Market Momentum Tracking - baoquankhu1.vn
Trading Action: Is LENZ Therapeutics Inc stock a buy or sellPortfolio Value Summary & Real-Time Volume Spike Alerts - baoquankhu1.vn
LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Unveiling a 155% Potential Upside in Biotechnology - DirectorsTalk Interviews
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc.LENZ - PR Newswire
Aug Spikes: What analysts say about LENZ Therapeutics Inc stockPortfolio Return Report & Risk Controlled Daily Plans - baoquankhu1.vn
We're Not Worried About LENZ Therapeutics' (NASDAQ:LENZ) Cash Burn - 富途资讯
Aug Shorts: Why is LENZ Therapeutics Inc stock going upProduct Launch & Weekly Stock Breakout Alerts - baoquankhu1.vn
Lenz Therapeutics Inc (LENZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lenz Therapeutics Inc 주식 (LENZ) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Olsson Shawn | Chief Commercial Officer |
Nov 17 '25 |
Sale |
26.10 |
10,000 |
261,022 |
4,733 |
3.69%
0.71%
자본화:
|
볼륨(24시간):